Consistent with these findings, we noticed that ADO itself triggers the production of the anti-inflammatory cytokine IL-10 in MNCs from COVID-19 patients and HDs (Figure 5B), indicating a possible mechanism by which ADO suppresses the production of inflammatory molecules. Here, IL10 is linked to COVID-19.